Ignite Creation Date:
2024-05-06 @ 9:56 AM
Last Modification Date:
2024-10-26 @ 12:22 PM
Study NCT ID:
NCT03118778
Status:
COMPLETED
Last Update Posted:
2018-07-12
First Post:
2017-04-13
Brief Title:
Proton Pump Inhibitor PPI Inappropriate Use and Economic Burden in Chinese Population
Sponsor:
AstraZeneca
Organization:
AstraZeneca
Study Overview
Official Title:
Proton Pump Inhibitor PPI Inappropriate Use and Economic Burden in Chinese Population A Descriptive Retrospective Observational Study Using Database
Status:
COMPLETED
Status Verified Date:
2018-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
ECHO
Brief Summary:
This is a descriptive retrospective database analysis study in using database All patients with a physician PPI prescription will be selected to estimate the PPI inappropriate use
Detailed Description:
Study primary objective is to identify the inappropriate use of PPI overall outpatient inpatient
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None